01—Abstract
Summary
Summary of the 8-K filed February 7, 2020. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. (CME) announced a significant leadership transition and changes to its corporate governance structure via an 8-K filing on February 6, 2020.
Bryan T. Durkin will step down as President in May 2020, transitioning to a special advisor role reporting to the CEO. This move signals a shift in executive responsibilities and is accompanied by an amendment to the company's bylaws.
The company's Board of Directors amended its bylaws to modify the nomination process for Class B Directors, effective February 5, 2020. Key changes include the elimination of Class B Nominating Committees starting from the 2021 annual meeting, with eligible nominees now to be selected by the Board's Nominating and Governance Committee alongside existing write-in requirements.
Additionally, the Nominating and Governance Committees have been formally combined into a single committee. These governance adjustments are designed to streamline the director nomination process.
02—Key points
Key Highlights
- Bryan T. Durkin to step down as President in May 2020.
- Mr. Durkin will assume a new role as a special advisor to the CEO.
- Bylaws amended to change the nomination process for Class B Directors, effective February 5, 2020.
- Class B Nominating Committees will be eliminated starting with the 2021 annual meeting.
- Nominees for Class B Directors will be selected by the Board's Nominating and Governance Committee and eligible write-in candidates from 2021 onwards.
- The Nominating and Governance Committees of the Board have been formally combined into one committee.
- The company issued a press release on February 6, 2020, detailing Mr. Durkin's transition.
03—Questions
Frequently Asked Questions
What is the impact of Bryan T. Durkin stepping down as President?
Bryan T. Durkin will transition from his role as President in May 2020 to become a special advisor to CME Group's Chairman and CEO, Terrence A. Duffy. This represents a significant leadership change and a shift in his operational responsibilities within the company.
What are the key changes to the company's bylaws regarding director nominations?
The company has amended its bylaws to streamline the nomination process for Class B Directors. Effective from the 2021 annual meeting, the Class B Nominating Committees will be eliminated. Nominees will instead be selected by the Board's Nominating and Governance Committee, in addition to satisfying existing write-in nomination requirements. The Nominating and Governance Committees themselves have also been formally combined.
When do these bylaw changes take effect?
The amendments to the bylaws were effective as of February 5, 2020. However, the elimination of the Class B Nominating Committees and the new nomination process for Class B Directors will be fully implemented starting with the 2021 annual meeting of shareholders.
Are there any immediate implications for the 2020 annual meeting regarding Class B Director nominations?
No, for the 2020 annual meeting of shareholders (scheduled for May 6, 2020), the nominations for Class B Directors will still be selected by the existing, applicable Class B Nominating Committees. There will be no election for new Class B Nominating Committees at this meeting.
04—Continue